Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Taylor Stone

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|December 3, 2025
mRNA-LNP Vaccines Encoding for Dengue Optimized prM/ENV Proteins Induce Protective Immunity without ADEEnzo LaMontia-Hankin, Clayton J Wollner, E Taylor Stone, et al.
Cell|February 28, 2026
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Nature Communications|January 14, 2025
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in miceDavid W Hawman, Thomas Tipih, Eddie Hodge, et al.
Frontiers in Immunology|September 4, 2023
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection modelAlexandria Dickson, Elizabeth Geerling, E Taylor Stone, et al.
Frontiers in Immunology|September 23, 2021
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus DiseaseAmelia K Pinto, Mariah Hassert, Xiaobing Han, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccinationCarlos A Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Science Advances|August 23, 2024
CD4<sup>+</sup> and CD8<sup>+</sup> T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2024
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|December 3, 2025
mRNA-LNP Vaccines Encoding for Dengue Optimized prM/ENV Proteins Induce Protective Immunity without ADEEnzo LaMontia-Hankin, Clayton J Wollner, E Taylor Stone, et al.
Cell|February 28, 2026
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Nature Communications|January 14, 2025
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in miceDavid W Hawman, Thomas Tipih, Eddie Hodge, et al.
Frontiers in Immunology|September 4, 2023
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection modelAlexandria Dickson, Elizabeth Geerling, E Taylor Stone, et al.
Frontiers in Immunology|September 23, 2021
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus DiseaseAmelia K Pinto, Mariah Hassert, Xiaobing Han, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccinationCarlos A Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Science Advances|August 23, 2024
CD4<sup>+</sup> and CD8<sup>+</sup> T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2024
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.
Pageof 3